Investigation of the mixed origins of the MGC-803 cell line reveals that it is a hybrid cell line derived from HeLa
Springer Science and Business Media LLC - Trang 1-7 - 2023
Tóm tắt
Human cancer cell lines have an essential role in cancer research, but only authentic cell lines should be used as biological models. Authentication testing using short tandem repeat (STR) loci has shown that MGC-803 cells, which were reported to come from gastric adenocarcinoma, are similar to HeLa. In this study, we confirmed that the MGC-803 cell line contains genetic material from HeLa, including genetic sequence from human papilloma virus 18 (HPV18). Additional alleles were present on STR analysis that remained stable after extensive passaging and generation of mono-clones. This behavior is consistent with a hybrid cell line arising from cell–cell fusion. Further genetic analysis revealed that MGC-803 originated from donors with different genetic ancestries, one African (HeLa) and the other Asian. Transcriptomic analysis demonstrated that MGC-803 closely resembles HeLa and another nasopharyngeal–HeLa hybrid cell line CNE-2. Based on these findings, we conclude that MGC-803 is a hybrid cell line derived from HeLa and other cells, the latter derived from a different patient with Asian genetic ancestry.
Tài liệu tham khảo
Mirabelli P, Coppola L, Salvatore M. Cancer cell lines are useful model systems for medical research. Cancers. 2019. https://doi.org/10.3390/cancers11081098.
Rojas A, Gonzalez I. Cell line cross-contamination: a detrimental issue in current biomedical research. Cell Biol Int. 2018;42:272.
American Type Culture Collection Standards Development Organization Workgroup ASN-0002. Cell line misidentification: the beginning of the end. Nat Rev Cancer. 2010;10(6):441–8.
Nardone RM. Eradication of cross-contaminated cell lines: a call for action. Cell Biol Toxicol. 2007;23:367–72.
Fusenig NE, Capes-Davis A, Bianchini F, Sundell S, Lichter P. The need for a worldwide consensus for cell line authentication: experience implementing a mandatory requirement at the International Journal of Cancer. PLoS Biol. 2017;15:e2001438.
Souren NY, Fusenig NE, Heck S, Dirks WG, Capes-Davis A, Bianchini F, Plass C. Cell line authentication: a necessity for reproducible biomedical research. EMBO J. 2022;41:e111307.
Capes-Davis A, Theodosopoulos G, Atkin I, Drexler HG, Kohara A, MacLeod RA, Masters JR, Nakamura Y, Reid YA, Reddel RR, Freshney RI. Check your cultures! A list of cross-contaminated or misidentified cell lines. Int J Cancer. 2010;127:1–8.
Horbach SPJM, Halffman W. The ghosts of HeLa: How cell line misidentification contaminates the scientific literature. PLOS One. 2017;12(10):e0186281.
Masters JR, Thomson JA, Daly-Burns B, Reid YA, Dirks WG, Packer P, Toji LH, Ohno T, Tanabe H, Arlett CF, Kelland LR, Harrison M, et al. Short tandem repeat profiling provides an international reference standard for human cell lines. Proc Natl Acad Sci USA. 2001;98:8012–7.
Barallon R, Bauer SR, Butler J, Capes-Davis A, Dirks WG, Elmore E, Furtado M, Kline MC, Kohara A, Los GV, MacLeod RA, Masters JR, et al. Recommendation of short tandem repeat profiling for authenticating human cell lines, stem cells, and tissues. In Vitro Cell Dev Biol Anim. 2010;46:727–32.
Ye F, Chen C, Qin J, Liu J, Zheng C. Genetic profiling reveals an alarming rate of cross-contamination among human cell lines used in China. FASEB J Off Publ Fed Am Soc Experimental Biol. 2015;29:4268–72.
Gu M, Yang M, He J, Xia S, Zhang Z, Wang Y, Zheng C, Shen C. A silver lining in cell line authentication: short tandem repeat analysis of 1373 cases in China from 2010 to 2019. Int J Cancer. 2022;150:502–8.
Wang K. The establishment and characteristic of human stomach adenocarcinoma cell line MGC-803. Acta Biologiae Experimentalis Sinica. 1983;16(3):257–67.
Huang Y, Liu Y, Zheng C, Shen C. Investigation of cross-contamination and misidentification of 278 widely used tumor cell lines. PLoS ONE. 2017;12:e0170384.
Li CX, Pakstis AJ, Jiang L, Wei YL, Sun QF, Wu H, Bulbul O, Wang P, Kang LL, Kidd JR, Kidd KK. A panel of 74 AISNPs: improved ancestry inference within Eastern Asia. Forensic Sci Int Genet. 2016;23:101–10.
Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357–9.
Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323.
Meissner JD. Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines. J Gen Virol. 1999;80:1725–33.
Geraghty RJ, Capes-Davis A, Davis JM, Downward J, Freshney RI, Knezevic I, Lovell-Badge R, Masters JR, Meredith J, Stacey GN, Thraves P, Vias M, et al. Guidelines for the use of cell lines in biomedical research. Br J Cancer. 2014;111:1021–46.
Nims RW, Reid Y. Best practices for authenticating cell lines. In Vitro Cell Dev Biol Anim. 2017;53:880–7.
Almeida JL, Cole KD, Plant AL. Standards for cell line authentication and beyond. PLoS Biol. 2016;14:e1002476.
Castro F, Dirks WG, Fahnrich S, Hotz-Wagenblatt A, Pawlita M, Schmitt M. High-throughput SNP-based authentication of human cell lines. Int J Cancer. 2013;132:308–14.
Chen X, Qian W, Song Z, Li QX, Guo S. Authentication, characterization and contamination detection of cell lines, xenografts and organoids by barcode deep NGS sequencing. NAR Genom bioinform. 2020. https://doi.org/10.1093/nargab/lqaa060.